DALLAS: Acadia Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin) for the treatment of Read More »

DALLAS: A type 2 diabetes drug could prevent Alzheimer’s disease from developing, new research has suggested.

A small study looking at Victoza (liraglutide), an injectable drug that lowers blood glucose levels, showed it offers protection from the brain disease.

A total of 38 people with Read More »

PHOENIX: “You don’t need to know much about nutrition to make sure you get plenty of antioxidants, you just need to eat a variety of colours – ideally five or six different coloured foods or shades of colour at each meal,” Ngaire Hobbins says.

So Read More »

DALLAS: In a previous study, the chronic skin condition rosacea was linked to an increased risk in Parkinson’s disease. In a new study, researchers associated the condition with a slightly heightened risk of having dementia.

Research spearheaded by Dr. Alexander Egeberg from the University of Read More »